(Total Views: 418)
Posted On: 05/13/2021 9:26:39 AM
Post# of 154105
Re: reallypeople? #89956
They approached us, not a result of Cytody approaching them. A hugely significant detail to this PR. Compassionate use could be immediate.
Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn ( CYDY ), stated, “We are delighted Macleods Pharmaceuticals reached out to CytoDyn ( CYDY ) and equally excited to reach this agreement with their team so quickly. From the time they first contacted us about our drug, we were able to conclude this agreement within a few days. It is an honor to work with an organization so motivated to bring leronlimab to COVID-19 patients in India. Currently India has zero product approved for critically ill Covid-19 patients and we are delighted to be working toward being the first approved drug for this population.”
Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn ( CYDY ), stated, “We are delighted Macleods Pharmaceuticals reached out to CytoDyn ( CYDY ) and equally excited to reach this agreement with their team so quickly. From the time they first contacted us about our drug, we were able to conclude this agreement within a few days. It is an honor to work with an organization so motivated to bring leronlimab to COVID-19 patients in India. Currently India has zero product approved for critically ill Covid-19 patients and we are delighted to be working toward being the first approved drug for this population.”
(6)
(0)
